tiprankstipranks
Trending News
More News >
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market

KYORIN Pharmaceutical Co.,Ltd. (4569) Income Statement

Compare
3 Followers

KYORIN Pharmaceutical Co.,Ltd. Income Statement

Last quarter (Q1 2025), KYORIN Pharmaceutical Co.,Ltd.'s total revenue was ¥30.23B, an increase of 6.37% from the same quarter last year. In Q1, KYORIN Pharmaceutical Co.,Ltd.'s net income was ¥2.10B. See KYORIN Pharmaceutical Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B¥ 102.90B
Gross Profit
¥ 59.51B¥ 51.41B¥ 50.17B¥ 49.44B¥ 51.63B
Operating Expenses
¥ 46.97B¥ 45.40B¥ 45.04B¥ 44.43B¥ 45.84B
Depreciation and Amortization
¥ 4.60B¥ 4.29B¥ 3.84B¥ 3.71B¥ 3.56B
EBITDA
¥ 17.55B¥ 11.37B¥ 10.81B¥ 8.72B¥ 11.98B
Operating Income
¥ 12.55B¥ 6.23B¥ 5.12B¥ 5.01B¥ 5.79B
Other Income/Expenses
¥ 203.00M¥ 1.01B¥ 1.78B¥ 209.00M¥ 2.57B
Pretax Income
¥ 12.77B¥ 7.24B¥ 6.91B¥ 5.22B¥ 8.35B
Net Income
¥ 9.09B¥ 5.47B¥ 4.72B¥ 3.93B¥ 6.13B
Per Share Metrics
Basic EPS
¥ 158.16¥ 92.74¥ 82.42¥ 68.62¥ 106.99
Diluted EPS
¥ 158.16¥ 92.74¥ 82.42¥ 68.62¥ 106.99
Weighted Average Shares Outstanding
57.45M 57.39M 57.30M 57.30M 57.30M
Weighted Average Shares Outstanding (Diluted)
57.45M 57.39M 57.30M 57.30M 57.30M
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History